Results
and Discussion
On the twent y-eighth day, all mice from all
treatment groups were still alive, had no
abnormal appearance, and then were entered for
examination and data analysis.
Mast cell count
Figure 1 in the study presents the count of mast
cells in the co ntrol group of endometriosis tissue
stained with toluidine blue. The average mast cell
counts in the control group and the groups
treated with ethanol extract of basil leaves at
doses of 0.21 mg/g -BW, 0.42 mg/g -BW, and 0.84
mg/g-BW were (3.86 ± 1.21), (4.0 0 ± 2.31), (1.71
± 1.11), and (0.86 ± 0.90), respectively, as
depicted in Figure 2. The data followed a normal
distribution, and a One -way ANOVA test revealed
a significant difference among the groups
(p=0.001). A Tukey's post hoc test was conducted
to compare the groups, indicating that the group
received dosage of 0.84 mg/g -BW of ethanol
extract of basil leaves exhibited a significant
distinction (p=0.005) compared to the control
group. Furthermore, the group treate d with 0.21
mg/gBW showed a significant di stinction
(p=0.039) compared to the groups administered
doses of 0.42 mg/g -BW and 0.84 mg/g -BW
(p=0.003).
Figure 1: Histology of endometriosis tissue stained with toluidine blue staining in each group. Mast cell s shown
in bluish color are indicated by red arrows (Nikon E100 light microscope with 400x magnification)
Insaniyah K.N., et al. / J. Med. Chem. Sci. 2023, 6(12) 2941-2951
2945 | P a g e
Figure 2: Mast cell count in endometriosis mice model
The One -way ANOVA analysis demonstrated a
noteworthy distinction with a p -value of 0.001.
The subsequent exam ination using Tukey's HSD
test for the average mast cell count produced the
following results:
(1) There was no notable distinction between the
control group and the intervention group with a
dose of 0.21 mg/g -BW (p=0.998), (2) A minor
distinction was obse rved between the control
group and the group treated with a dose of 0.42
mg/g-BW (p=0.057), and (3) A significant
distinction was found between the control group
and the intervention group of 0.84 mg/g -BW
(p=0.005).
Furthermore, the followi ng nota ble disti nctions
were observed:
(1) There existed a significant distinction
between the intervention group treated with a
dose of 0.21 mg/g -BW and the intervention
group treated with 0.42 mg/g -BW (p=0.039), (2)
A significant distinction was found be tween the
intervention group treated with of 0.21 mg/g-BW
and the intervention group treated with 0.84
mg/g-BW (p=0.003); however, (3) No significant
distinction was detected between the
intervention group treated with 0.42 mg/g -BW
and the intervention gro up treated with 0.84
mg/g-BW (p=0.706).
PGE2 levels
The mean PGE2 levels in the control group, th at
given ethanol extract of basil leaves at doses of
0.21 mg/gBW, 0.42 mg/gBW, and 0.84 mg/gBW
were (44.52 ± 11.99), (41.95 ± 5.36), (50.73 ±
4.44), and (44.39 ±6.53), respecti vely ( Figure 3).
The One -way ANOVA test was used because the
data were normally distributed and the results
showed no significant distinction between groups
(p=0.199). This non -significant difference was
due to variations in the expressed PGE2 values. In
the control group, 2/7 rats had lower PGE2 levels
than the group given ethanol extract of basil
leaves with 0.21 mg/g -BW, 0.42 mg/g -BW, and
0.84 mg/g -BW. In the data proportion on PGE2
levels, the 0.42 mg/g -BW dose gr oup had the
highest average compared to the other groups .
This study examined the mast cell count in the
control group and observed an ele vation in both
degranulated and overall mast cell numbers
within endometriosis lesions, indicating their
involvement i n inflammatory disease
development [10].
Endometriosis patients displayed signific antly
higher mast cell counts and increased
degranulation in endometriotic lesions compared
to the other tissues. This phenomenon was
particularly prominent in deep infiltrating lesions
and regions proximate to nerve fibers [22],
aligning with Kempuraj et al . (2004) findings of
elevated mast cell density per square mill imeter
and 89% activation among endometriosis
patients [23]. In addition, Borelli et al. (2020)
found that mast cell degrees in the peritoneal
fluid were significantly higher in women with
endometriosis (2.8 ± 3.2) compar ed to healthy
women (0.5 ± 0.5) (p < 0.05) [24].
Insaniyah K.N., et al. / J. Med. Chem. Sci. 2023, 6(12) 2941-2951
2946 | P a g e
Figure 3: PGE2 levels in the endometriosis mouse model. The One-way ANOVA test exposed no significant
distinction p=0.199
Endometriosis lesions contain degranulated mast
cells that release proteases, leading to the
production of histamine -releasing peptides and
cytokines [10].
Mast cell activation is implicated in the formation
of fibrous adhesions that contribute to
endometriosis lesions, scarring, and fibrosis [25].
Activated mast cells also produce mediators like
histamine and TNF-α that indirectly contribute to
neuropathic pain by recruiting leukocytes [26]. In
patients with endometriosis, the number of
degranulated and activated mast cells
significantly increases in deep infiltrating lesions
and those located near ne rves, which are the
most painful lesions. Anaf et al . (2006) showed
that deep infiltrating lesions are associated with
higher pain scores, suggesting a link between
mast cells and pain in endometriosis [27].
In the present study, treating the subjects with
ethanol extract of basil leaves at a dosage of 0.84
mg/g-BW led to a notable decrease in mast cell
count in comparison to the control group, with a
significant difference observed (p=0.005). Basil
leaves contain the flavonoid quercetin and
rosmaniric acid, which act as mast cell stabilizers.
The stabilization mechanism of mast cells in basil
leaves suppresses the inhibition of IgE
production in preventing cross-linking of the IgE-
FcεRI complex to prevent the development of
mast cell degranulation [28].
Mast cells can be activated by interacting directly
with antigens (IgE -dependent pathway), where
IgE production requires the release of T -helper2
(Th2) cytokines, namely IL -4, IL -5, and IL -13.
Although there is increased expression of IL -4 in
the peritoneal fluid of endomet riosis patients,
further studies regarding mast cell activation in
IgE-dependent endometriotic lesions have not
been confirmed [22].
The reduction in mast cell count can be
characterized to the inhibitory effects of
quercetin present in basil leaves. Quercetin
inhibits mast cell activation by blocking calcium
ion influx, sup pressing the release of histamine,
leukotrienes, and prostaglandins, and inhibiting
protein kinase activation [29].
Release of Ca 2+ from the extracellular matrix
activates mast cells and causes NFkB to
translocate to the cell nu cleus, which results in
cytokine transcription [30, 31].
Research conducted by Ding et al. (2019), proved
that quercetin was significantly dose -dependent
on being able to stabilize peritoneal mast cells by
reducing Ca2+ expenditure [32].
Basil leaves co ntain a variety of antioxidants,
such as vitamin C, vitamin E, carotenoids, and
flavonoids, which help safeguard against
oxidative stress and the harmful effects of free
radicals induced by hepatotoxic substances.
These substances have the potential to har m
cellular structures and trigger the manufacturing
of Reactive Oxygen Species (ROS) [33].
Flavonoids can reduce mast cell secretion by
adding a hydroxyl group at position 2', which can
interact with oxygen at position 1 to form a cyclic
structure that could interfere with various
biological events [34].
Insaniyah K.N., et al. / J. Med. Chem. Sci. 2023, 6(12) 2941-2951
2947 | P a g e
Furthermore, flavonoids can decrease the
number of mast cells by inhibiting the activity of
phosphatidylinositol-3-phosphate kinase (PI3K)
enzyme and activating AMP -activated protein
kinase (AM PK). This mechanism provides anti -
inflammatory and anti -cancer effects. Mast -cell
degranulation and activation can be through the
PI3K enzyme pathway. Flavonoids contained in
basil leaves such as quercetin can also inhibit
mast cell degranulation in acute inflammation by
inhibiting PGE2 production via arachidonic acid
[35].
In a study conducted by Park et al. (2008), it was
shown that flavonoids have inhibitory properties
on mast cell degranulation and activation. These
specific compounds were observed to hinder the
release of histamine and inflammatory
substances generated by mast cells. This
inhibition resulted in the suppression of NF -Kb
binding, the release of pro -inflammatory
cytokines (IL -6, IL -8, TNF-α, and IL-1β), and
histamine release (p<0.05) [36].
In patients diagnosed with endome triosis, there
is an increase in macrophage count. These
macrophages are responsible for enhancing the
secretion of cytokines, which play a significant
role in the development of lesions, angiogenesis,
and proliferation. Endometriosis patients also
exhibit elevated levels of proin flammatory
cytokines such as interleukins -1, -8, -33, nuclear
factor kappa B (NF -κB), and tumor necrosis
factor alpha (TNF-α) [37].
In estrogen -induced endometriosis (E2), the
signaling pathway involving cyclooxygenase -2
(COX-2), omega -3 PUFA, and IL -1β leads to an
increase in NF -κB activity. Consequently, COX -2
promotes the manufacturing of prostaglandin E2
(PGE2) [38].
PGE2, in turn, regulates steroidogenesis by
inducing the expression of steroidogenic acute
regulatory protein (StAR) and aromatase. This
enables the production of de novo estrogen from
cholesterol without the need for intermediate
metabolite transport from other organs.
Moreover, estrogen plays an important role in
angiogenesis by stimulating VEGF expression and
inducing endothelial cell proliferation [7].
Prostaglandin E2 also inhibits apoptosis and
increases cell proliferation by inducing the
expression of fibroblast growth factor 9 (FGF -9)
and matrix metalloproteinase -2 (MMP -2) [39].
Increased levels of PGE2 can cause inflammatory
mediators to escape from blood vessels to local
areas, causing dysmenorrhea [40].
Administration of ethanol extract of basil leaves
as a complementary treatment showed no
significant reduction in PGE2 levels (p=0.199),
but in doses of 0.21 mg/g -BW (41.95±5.36) and
0.84 mg/g -BW (44.39±6.53) it reduced the
average levels of PGE2 compared to the control
group (44.52±11.99). Administration of ethanol
extract of basil leaves at a dose of 0.21 mg/g -BW
and a dose of 0.84 mg/g -BW reduced the average
PGE2 level although not statistically significant.
The mechanism of ethanol extract of basil leaves
in reducing the average PGE2 level is by reducing
the transfer of Nf -kb into the nucleus by
inhibiting the Nfkb1 gene, which in turn
suppresses inflammatory cytokine genes through
inhibition of Nf -kB function which will affect
TLR4-Nf-kB signaling [16].
The mechanism of basil leaves in anti -
inflammation is through the inhibition of
arachidonic acid through the lipoxygenase and
cyclooxygenase pathways thereby suppressing
the production of PGE2 levels [15]. Numerous
studies have confirmed the efficacy of different
types of flavonoids in suppressing endometriosis,
a condition that impacts over 5.5 million women
in the United States , and 176 million women in
worldwide [41].
A meta -analysis conducted by Jalali et al. found
that the flavonoid quercetin has the potential to
decrease symptoms and levels of PGE2 (42).
Another study by Umar et al. (2014) supported
this finding, demonstrating that the ethanol
extract of basil leaves (Ocimum basilicum L.)
could decrease PGE2 production and inhibit COX
enzymes (COX -1 and COX -2) by reducing
macrophage activation [17].
The group that received the ethanol extract of
basil leaves with 0.42 mg/g -BW showed an
abnormal increase in PGE2 levels compared to
the other treatment groups, which experienced a
decrease. The atypical rise can be ascribed to
genetic and protein variations and mutations,
leading to alterations in observable
characteristics. Mutations can arise from either
Insaniyah K.N., et al. / J. Med. Chem. Sci. 2023, 6(12) 2941-2951
2948 | P a g e
inherited genetic changes passed down from
parents (germline mutations) or acquired
mutations that occur during an individual's
lifetime (somatic mutations), with the latter
being a major contributor to disease [43].
In Wang & Song's study (2015) where the genetic
variation of COX -1195 is at risk for
endometriosis. The COX -2 1195 AA genotype
frequency and the A allele frequency were
significantly higher than the control group. Allele
A is consistent in the function of the -1195 G>A
polymorphism, which can form a c -Myb binding
site and significantly increase the activity of the
COX-2 gene promoter in regulating the balance
between cell division, survival, and
differentiation resulting in endometriosis [44].
Administration of basil leaf extract ( Ocimum
basilicum L.) to endometriosis mice experienced
an increase in PGE2 levels with increasing doses.
This could be due to the content of phytochemical
compounds such as euginal, euginol, sitosterol,
ursolic acid , and stigmasterol in basil leaves
which act as phytoandrogens or phytoestrogens
[45].
Basil leaves (Ocimum basilicum L.) contain
orientin, vicenin, and isoflavones which are
estrogenic which can increase exogenous
estrogen, bind to estrogen receptors in the body,
and proliferate the uterus [19, 46, 47].
Isoflavones can cause an estrogen -raising effect
in many tissues. The content of systesterol and
stigmasterol in basil leaves is androgenic.
Sitosterol and stigmasterol are androgen
precursors that can be converted into
testosterone, resulting in higher testosterone
levels and suppressing the development of
ovarian follicles [45].
Giving ocimum basilicum L. leaf extract which has
estrogenic content has caution in the use of
endometriosis treatment, where estrogen is a key
hormone for the growth and persistence of
endometriosis tissue as well as inflammation and
pain [48].
The rise in PGE2 can also be triggered by mast
cells that have been activated. When women with
endometriosis lesions have activated mast cells,
they produce soluble products like TNF -α, IL-4,
IL-5, and IL-6. These products then stimulate
fibroblasts to produce collagenase and PGE2, and
induce macrophages t o produce pro -
inflammatory factors in the endometrium [25].
Disclosure Statement
No potential conflict of interest was reported by
the authors.
Funding
This research did n ot receive any specific grant
from funding agencies in the public, commercial,
or not-for-profit sectors.
Authors' Contributions
All authors contributed to data analysis, drafting,
and revising of the paper and agreed to be
responsible for all the aspects of this work.
Orcid
Khafidhiyah Nur Insaniyah
https://orcid.org/0009-0007-4770-8216
Ashon Sa’adi
https://orcid.org/0000-0003-2682-3139
Widjiati Widjiati
https://orcid.org/0000-0002-8376-1176
References
[1]. Laganà A .S., Garzon S ., Götte M ., Viganò P .,
Franchi M ., Ghezzi F ., Martin D.C., The
pathogenesis of endometri osis: Molecular and
cell biolo gy insights , International journal of
molecular sciences., 2019, 20:1 [Crossref], [Google
Scholar], [Publisher]
[2]. Moen M .H., Endometriosis, an everlasting
challenge, Acta Obstetricia et Gynecologica
Scandinavica., 2017, 96:783 [Crossref], [Google
Scholar], [Publisher]
[3]. Zondervan K .T., Becke r C .M., Missmer. SA.
Endometriosis, Review Article , N Engl J Med .,
2020, 382:56 [Crossref], [Publisher]
[4]. Parasar P., Ozcan P ., Terry K. , Endometriosis:
Epidemiology, Diagnosis and Clinical
Management, Current obstetrics and gyne cology
reports., 2016, 26:196 [Crossref], [Google
Scholar], [Publisher]
[5]. Guo Y., Liu F.Y., Shen Y., Xu J.Y., Xie L.Z., Li S.Y.,
Ding D. N., Zhang D.Q., Han F.J., Complementary
and Alternative Medicine for Dysmenorrhea
Insaniyah K.N., et al. / J. Med. Chem. Sci. 2023, 6(12) 2941-2951
2949 | P a g e
Caused by Endometriosis: A Review of Utilization
and Mechanism , Evidence-Based Complementary
and Alternative Medicine ., 2021, 2021 [Crossref],
[Google Scholar], [Publisher]
[6]. Moradi M ., Parker M ., Sne ddon A ., Lopez V .,
Ellwood D., Impact of endometriosis on women’s
lives: A qualitative study , BMC women's health .,
2014, 14:1 [Crossref], [Publisher]
[7]. Hsiao K. Y., Wu M .H., Tsai S .J., Roles of
Prostaglandin E 2 in Endometriosis ,
Endometriosis: Pathogenesis a nd Treatment .,
2014, 1 25 [Crossref], [Google Scholar ],
[Publisher]
[8]. Tsuge K., Inazumi T., Shimamoto A., Sugimoto
Y., Molecular mechanisms underlying
prostaglandin E2 -exacerbated inflammation and
immune diseases , International immunology .,
2019, 31:597 [Crossref], [Google Scholar ],
[Publisher]
[9]. Taylor H .S., Pal L ., Seli E. , Speroff’s Clinical
Gynecologic Endocrinology and Infertility ,
Connecticut: Wolters Kluwer ., 2020, 580
[Publisher]
[10]. McCallion A., Nasirzadeh Y ., Lingegowda H .,
Miller J .E., Khalaj K ., Ahn S ., Monsanto S .P.,
Bidarimath M., Sisnett D.J., Craig A.W., Young S.L.,
Lessey B.A., Koti M., Tayade C., Estrogen mediates
inflammatory role of mast cells in endometriosis
pathophysiology, Frontiers in Immunology ., 2022,
13:961599 [Crossref], [Google Scholar ],
[Publisher]
[11]. a) Ilhan M ., Gürağaç Dereli F .T., Akkol E .K.,
Novel Drug Targets with Traditional Herbal
Medicines for Overcoming End ometriosis,
Current Drug Delivery ., 2018, 16:386 [Crossref],
[Google S cholar], [ Publisher]; b) Hamood Al -
Behadili W.K., Jawad Y.M., Hasan H.J. Study the
Effect of pH on Absorption and Fluorescence
Spectra of Eosin Y Dye in Ethanol. Asian Journal of
Green Chemistry , 2023, 7:163 [Crossref],
[Publisher]; c) Ahmadyousefi Y., A brief overview
of plant -derived chemotherapeutic agents for
cancer therapy. Asian Journal of Green Chemistry ,
2023, 7:175 [Crossref], [Publisher]
[12]. a) Nimesh S., Ashwlayan V.D., R ani R.,
Prakash O., Advantages of Herbal Over Allopathic
Medicine in the Management of Kidney and
Urinary Stones Diseas , Borneo Journal of
Pharmacy., 2020, 3:179 [Crossref], [Google
Scholar], [ Publisher]; b) Monjezi A., Karimian P.,
Yousofvand V. Therapeutic applications of
Salvadora persica plant in medical sci ences: a
review article. Asian Journal of Green Chemistry ,
2023, 7:180 [ Crossref], [Publisher]; c)
Akbarnejad F., Dermatology Benefits of Punica
granatum: A Review of the Potential Benefits of
Punica granatum in Skin Disorders. Asian Journal
of Green Chemistry , 2023, 7:208 [ Crossref],
[Publisher]
[13]. Filip S. , Internation f Valuable
Phytonutrients, J Clin Nutr Diet ., 2017, 3
[Crossref], [Google Scholar], [Publisher]
[14]. Shahrajabian M .H., Sun W ., Cheng Q. ,
Chemical components and phar macological
benefits of Basil (Ocimum basilicum): a review ,
International Journal of Food Properties ., 2020,
23:1961 [Crossref], [Google Scholar], [Publisher]
[15]. Eftekhar N ., al Moghimi A ., Mohammadian
Roshan N ., Sa adat S ., Boskabady M .H.,
Immunomodulatory and anti -inflammatory
effects of hydro -ethanolic extract o f Ocimum
basilicum leaves and its effect on lung
pathological changes in an ovalbumin-induced rat
model of asthma , BMC complementary and
alternative medicin e., 2019, 19:1 [Crossref],
[Publisher]
[16]. Takeuchi H., Takahashi-Muto C., Nagase M .,
Kassai M ., Tanaka -Yachi R ., Kiyose C. , Anti-
inflammatory effects of extracts of sweet basil
(Ocimum b asilicum l.) on a co -culture of 3t3 -l1
adipocytes and raw264.7 macrophages, Journal of
oleo science ., 2020, 69:487 [Crossref], [Google
Scholar], [Publisher]
[17]. Umar A., Zhou W ., Abdusalam E ., Tursun A .,
Reyim N ., Tohti I ., Moore N., Effect of Ocimum
basilicum L. on cyclo-oxygenase isoforms and
prostaglandins involved in thrombosis , Journal of
ethnopharmacology., 2014, 152:151 [Crossref],
[Google Scholar], [Publisher]
[18]. Scholten D., Trebicka J., Liedtke C.,
Weiskirchen R., The carbon tet rachloride model
in mice , Laboratory Animals ., 2015, 49:4
[Crossref], [Google Scholar], [Publisher]
[19]. Andriyanto A ., Widi L .N., Subangkit M .,
Tarigan E ., Irarang Y ., Nengsih R .F., Manalu W.,
Potential use of Ind onesian basil (Ocimum
basilicum) maceration to increase estradiol and
progesterone synthesis and secretion to improve
Insaniyah K.N., et al. / J. Med. Chem. Sci. 2023, 6(12) 2941-2951
2950 | P a g e
prenatal growth of offspring using female albino
rats as an ani mal model, Veterinary World., 2022,
15:1197 [Crossref], [Google Scholar], [Publisher]
[20]. Trisetiyono Y ., Widjiati W ., Hidayat S .T.,
Pramono N., Antioxidant Herbs Supplementation
Inhibits Endometriosis Extension in Mice, Journal
of Biomedicine and Translational Research ., 2019,
5:53[Crossref], [Google Scholar], [Publisher]
[21]. Iuvone T ., Affaitati G ., De Filippis D .,
Lopopolo M ., G rassia G ., Lapenna D, Negro L.,
Costantini R., Vaia M., Cipollone F., Ialenti A.,
Ultramicronized palmitoylethanolamide reduces
viscerovisceral hyperalgesia in a rat model of
endometriosis plus ureteral calculosis: Role of
mast cells, Pain., 2016, 157:80 [Google Scholar ],
[Publisher]
[22]. Binda M .M., Donnez J ., Dolmans M .M.,
Targeting mast cells: a new way to treat
endometriosis, Expert opinion on therapeutic
targets., 2017, 21:67 [Crossref], [Google Scholar],
[Publisher]
[23]. Mariuzzi L., Domenis R., Orsar ia M.,
Marzinotto S., Londero A.P., Bulfoni M., Candotti
V., Zanello A., Ballico M., Mimmi M.C., Calcagno A.,
Functional Expression of Aryl Hydroca rbon
Receptor on Mast Cells Populating Human
Endometriotic Tissues , Laboratory Investigation .,
2016, 96:959 [Crossref], [Google Scholar ],
[Publisher]
[24]. Borelli V ., Martinelli M ., Luppi S ., Vita F .,
Romano F ., Fanfani F ., Trevisan E., Celsi F.,
Zabucchi G., Zanconati F., Bottin C., Mast Cells in
Peritoneal Fluid From Women With
Endometriosis and Their Possible Role i n
Modulating Sperm Function , Frontiers in
Physiology., 2020, 10 [Crossref], [Google Scholar],
[Publisher]
[25]. Vallvé-Juanico J., Houshdaran S., Giudice L.C.,
The endometrial immune environment of women
with endometriosis, Human reproduction update.,
2019, 25:565 [Crossref], [Google Scholar ],
[Publisher]
[26]. Zhu T .H., Zou G ., Ding S .J., Li T .T., Zhu L .B.,
Wang J.Z., Yao Y.X., Zhang X.M., Mast cell stabilizer
ketotifen reduces hyperalgesia in a rodent model
of surgically induced endometrio sis, Journal of
pain research ., 2019, 12:1359 [Google Scholar ],
[Publisher]
[27]. Maddern J ., Grundy L ., Castro J ., Brierley
S.M., Pain in Endometriosis , Frontiers in cellular
neuroscience., 2020, 14:590823 [Crossref],
[Google Scholar], [Publisher]
[28]. Sim L .Y., Rani N .Z.A., Husain K. , Lamiaceae:
An insight on their anti -allergic potential and its
mechanisms of action, Frontiers in pharmacology.,
2019, 10:677 [Crossref], [Google Scholar ],
[Publisher]
[29]. Mlcek J., Jurikova T., Skrovankova S., Sochor
J., Quercetin and it s anti -allergic immune
response, Molecules., 2016, 21:623 [Crossref],
[Google Scholar], [Publisher]
[30]. Komi D .E.A., Wöhrl S ., Bielory L. , Mast Cell
Biology at Molecular Level: a Comprehensive
Review, Clinical reviews in allergy & immunology .,
2020, 58:342 [Crossref], [Google Scholar ],
[Publisher]
[31]. Krystel-Whittemore M., Dileepan K.N., Wood
J.G., Mast cell: A multi -functional master cell ,
Frontiers in immunology ., 2016, 6:1 [Crossref],
[Google Scholar], [Publisher]
[32]. Ding Y ., Che D ., Li C ., Ca o J ., Wang J ., Ma P .,
Zhao T., An H., Zhang T., Quercetin inhibits
Mrgprx2-induced pseudo -allergic reaction via
PLCγ-IP3R re lated Ca 2+ fluctuations ,
International immunopharmacology ., 2019,
66:185 [Crossref], [Google Scholar], [Publisher]
[33]. Renovaldi D., Adam A .K., Potential of Sweet
Basil (Ocimum basilicum) as a Hepatoprotector
Agent for Liver Injury Related to Drug s,
Muhammadiyah Medical Journal ., 2020, 1:63
[Crossref], [Google Scholar], [Publisher]
[34]. Al-Khayri J.M., Sahana G.R. , Nagella P.,
Joseph B.V., Alessa F.M., Al-Mssallem M.Q. ,
Flavonoids as Potential Anti -Inflammatory
Molecules: A Review , Molecules., 2022, 27:2901
[Crossref], [Google Scholar], [Publisher]
[35]. Shaik Y ., Caraffa A ., Ronconi G ., Lessiani G .,
Conti P., Impact of polyphenols on mast cells with
special emphasis on the effect of quercetin and
luteolin, Central European Journal of
Immunology., 2018, 43:476 [Crossref], [Google
Scholar], [Publisher]
[36]. Rakha A., Umar N., Rabail R., Butt M.S.,
Kieliszek M., Hassoun A., Aadil R.M., Anti-
inflammatory and anti -allergic potential of
dietary flavonoids: A review , Biomedicine &
Insaniyah K.N., et al. / J. Med. Chem. Sci. 2023, 6(12) 2941-2951
2951 | P a g e
Pharmacotherapy., 2022, 156:113945 [Crossref],
[Google Scholar], [Publisher]
[37]. Donnez J., Cacciottola L. , Endometriosis: An
Inflammatory Disease That Requires New
Therapeutic Options , International Journal of
Molecular Sciences ., 2022, 23:1518 [Crossref],
[Google Scholar], [Publisher]
[38]. Lai Z.Z., Yang H.L., Ha S.Y., Chang K.K., Mei J.,
Zhou W .J., Qiu X.M., Wang X.Q., Zhu R., Li D.J., Li
M.Q., Cyclooxygenase-2 in endometriosis ,
International journal of biological scie nces., 2019,
15:2783 [Crossref], [Google Scholar], [Publisher]
[39]. Nasry W.H.S., Rodr iguez-Lecompte J.C.,
Martin C.K., Role of COX -2/PGE2 Mediated
Inflammation in Oral Squamous Cell Carcinoma ,
Cancers., 2018, 10:348 [Crossref], [Google
Scholar], [Publisher]
[40]. Huang Q., Liu X ., Guo S. , Changing
prostaglandin E2 (PGE 2 ) signaling during
lesional progression and exacerbation of
endometriosis by inhibitio n of PGE 2 receptor
EP2 and EP4, Reproductive Medicine and Biology .,
2022, 21:12426 [Crossref], [Google Scholar ],
[Publisher]
[41]. Safe S., Jayaraman A ., Chapkin R .S., Howard
M., Mohan kumar K ., Shrestha R. , Flavonoids:
structure–function and mechanisms of action and
opportunities for drug development ,
Toxicological Research ., 2021, 37:147 [Crossref],
[Google Scholar], [Publisher]
[42]. Jalali M., Mahmoodi M., Moosavian S.P., Jalali
R., Ferns G ., Mosallanezhad A ., Imanieh M.H.,
Mosallanezhad Z., The effects of ginger
supplementation on markers of inflammatory
and oxidative stress: A systematic review and
meta-analysis of clinical trials , Phytotherapy
Research., 2020, 34:1723 [Crossref], [Google
Scholar], [Publisher]
[43]. Karki R ., Pandya D ., Elst on R .C., Ferlini C. ,
Defining ‘mutation’ and ‘polymorphism’ in the era
of personal genomics , BMC medical genomics .,
2015, 8:1 [Crossref], [Google Scholar], [Publisher]
[44]. Wang Y., Qu Y., Song W., Genetic variation in
COX-2 -1195 and the risk of endometriosis and
adenomyosis, Clin Exp O bstet Gynecol ., 2015,
42:168 [Google Scholar], [Publisher]
[45]. Maryanti S ., Nasihun T ., Amalia H. , The
Effect of Administering Lemon Basil ( Ocimum
sanctum ) Leaves on FSH and LH Estrogen Levels
and Size of Ovarian Antral Follicle in Female Balb
/ C Mice, Sains Medika: Jurnal Kedokteran dan
Kesehatan., 2019, 10:57 [Google Scholar ],
[Publisher]
[46]. Mousavi L ., Salleh R .M., Murugaiyah V. ,
Phytochemical and bioactive compounds
identification of Ocimum tenuiflorum leaves of
methanol extract and its fraction with an
antidiabetic potential , International Journal of
Food Properties ., 2018, 21:2390 [Crossref],
[Google Scholar], [Publisher]
[47]. Farhana A., Reddy A ., Bhavana K ., Mutha S .,
Bakshi V ., Assessment of Ocimum Sanctum To
Normalize the Estrous Cycle in Letrazole Induced
Polycystic Ovary, World J Pharm Res., 2018, 7:907
[Google Scholar], [Publisher]
[48]. Antonescu A.I., Miere F ., Fritea L., Ganea M .,
Zdrinca M., Dobjanschi L., Antonescu A., Vicas S.I.,
Bodog F., Sindhu R.K., Cavalu S., Perspectives on
the combined effects of ocimum basilicum and
trifolium pratense extracts in terms of
phytochemical prof ile and pharmacological
effects, Plants., 2021, 10:1390 [Crossref], [Google
Scholar], [Publisher]
HOW TO CITE THIS ARTICLE
Khafidhiyah Nur Insaniy ah*, Ashon Sa’adi, Widjiati , Impact of Ethanol Extract of Basil Leaves (Ocimum basilicum L.) on
Mast Cell Reduction and Prostaglandin E2 Levels in Female Mice as a Model for Endometriosis Developmen t. J. Med.
Chem. Sci., 2023, 6(12) 2941-2951.
DOI: https://doi.org/10.26655/JMCHEMSCI.2023.12.9
URL: https://www.jmchemsci.com/article_176669.html